2006
DOI: 10.1016/j.neuint.2005.08.014
|View full text |Cite
|
Sign up to set email alerts
|

PTEN levels in Alzheimer's disease medial temporal cortex

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
18
0
2

Year Published

2006
2006
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(25 citation statements)
references
References 38 publications
5
18
0
2
Order By: Relevance
“…However, another study showed that acute exposure of primary mouse neurons to Aβ42 up-regulated Akt phosphorylation (27). More importantly, an increase in Akt activity was found in the temporal cortex of the postmortem AD brain, suggesting an upregulated PI3K/Akt pathway in patients (28)(29)(30). Consistent with the postmortem study, our in vivo analysis revealed that accumulation of Aβ42 seemed to increase PI3K activity at the larval NMJ, larval ganglion neurons, and the adult brain.…”
Section: Discussionsupporting
confidence: 86%
“…However, another study showed that acute exposure of primary mouse neurons to Aβ42 up-regulated Akt phosphorylation (27). More importantly, an increase in Akt activity was found in the temporal cortex of the postmortem AD brain, suggesting an upregulated PI3K/Akt pathway in patients (28)(29)(30). Consistent with the postmortem study, our in vivo analysis revealed that accumulation of Aβ42 seemed to increase PI3K activity at the larval NMJ, larval ganglion neurons, and the adult brain.…”
Section: Discussionsupporting
confidence: 86%
“…Cdc25A and Cdc25B are activated in the degenerating postmitotic neurons of AD patients (65,66). PTEN, a major negative regulator of the PI3k/Akt pathway, was found to be significantly less expressed in AD neurons, as well as being altered in distribution (49,67). However the underlying mechanism governing altered phosphatase activity remains to be investigated.…”
Section: +mentioning
confidence: 99%
“…Clinical manifestations of inherited PTEN mutation occur with highly variable penetrance and also include benign hamartomas in multiple tissues, macrocephaly, seizures, ataxia, mental retardation and autism in addition to cancer predisposition (Ali et al, 1999, Goffin et al, 2001, Eng, 2003, Butler et al, 2005. Changes in PTEN levels have recently been linked to Alzheimer's disease (Zori et al, 1998, Goffin et al, 2001, Butler et al, 2005, Griffin et al, 2005, Rickle et al, 2006. While the tumor suppressor activity of Pten has been extensively studied in multiple tissue types, work relating Pten loss of function to neuronal dysfunction has only recently been studied.…”
mentioning
confidence: 99%